Citadel Advisors’s Tivity Health, Inc. Common Stock TVTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
– Sell
-52,300
Closed -$1.21M – 15330
2021
Q3
$1.21M Buy
52,300
+18,700
+56% +$444K ﹤0.01% 7666
2021
Q2
$884K Sell
33,600
-4,900
-13% -$123K ﹤0.01% 8675
2021
Q1
$859K Buy
38,500
+11,394
+42% +$261K ﹤0.01% 8483
2020
Q4
$531K Buy
27,106
+10,306
+61% +$171K ﹤0.01% 8039
2020
Q3
$236K Sell
16,800
-64,200
-79% -$927K ﹤0.01% 8557
2020
Q2
$918K Buy
81,000
+43,800
+118% +$400K ﹤0.01% 5992
2020
Q1
$234K Buy
37,200
+23,800
+178% +$384K ﹤0.01% 7744
2019
Q4
$273K Sell
13,400
-12,100
-47% -$226K ﹤0.01% 7742
2019
Q3
$424K Buy
25,500
+7,600
+42% +$131K ﹤0.01% 7029
2019
Q2
$294K Sell
17,900
-3,900
-18% -$75.3K ﹤0.01% 7616
2019
Q1
$383K Sell
21,800
-9,600
-31% -$204K ﹤0.01% 7240
2018
Q4
$779K Buy
31,400
+4,000
+15% +$133K ﹤0.01% 5703
2018
Q3
$881K Buy
+27,400
New +$935K ﹤0.01% 5774
2015
Q4
– Sell
-6,400
Closed -$71K – 9382
2015
Q3
$71K Sell
6,400
-2,200
-26% -$26.9K ﹤0.01% 7290
2015
Q2
$103K Buy
8,600
+1,100
+15% +$18.3K ﹤0.01% 7046
2015
Q1
$148K Buy
7,500
+200
+3% +$4.18K ﹤0.01% 6502
2014
Q4
$145K Buy
7,300
+3,200
+78% +$52.3K ﹤0.01% 6314
2014
Q3
$66K Sell
4,100
-6,600
-62% -$112K ﹤0.01% 6715
2014
Q2
$188K Buy
10,700
+5,600
+110% +$96.2K ﹤0.01% 5636
2014
Q1
$87K Sell
5,100
-41,700
-89% -$642K ﹤0.01% 6331
2013
Q4
$718K Buy
46,800
+40,500
+643% +$575K ﹤0.01% 3578
2013
Q3
$117K Buy
+6,300
New +$114K ﹤0.01% 5231

Other funds holding TVTY

Citadel Advisors's TVTY Position: Q2 2022 in Review

Citadel Advisors sold out of Tivity Health, Inc. Common Stock (TVTY) in Q2 2022, closing a stake of 163,892 shares — an estimated $5.27M sold.

Citadel Advisors first reported a position in TVTY in Q3 2013 and held it in 30 quarters. The position peaked at $14.6M in Q4 2018. 4 funds tracked by Wall St. Rank hold TVTY as of Q2 2022.

  • Citadel Advisors reported no remaining Tivity Health, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Citadel Advisors sold 163,892 Tivity Health, Inc. Common Stock shares in Q2 2022, an estimated $5.27M.
  • Citadel Advisors first reported a position in Tivity Health, Inc. Common Stock in Q3 2013 and held it in 30 quarters.
  • Citadel Advisors's Tivity Health, Inc. Common Stock position peaked at $14.6M in Q4 2018.
  • 4 funds tracked by Wall St. Rank held Tivity Health, Inc. Common Stock as of Q2 2022.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.